Krystal Biotech buy Bank of America Co.
Start price
17.10.25
/
50%
€159.10
Target price
17.10.26
€217.90
Performance (%)
36.27%
Price
30.12.25
€216.80
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ for Krystal Biotech has seen massive gains of 36.27%. This prediction currently runs until 17.10.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 0.790% | 0.790% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Bank of America Corporation from $182.00 to $255.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€129.30
22.07.25
22.07.25
€164.24
22.07.26
22.07.26
67.67%
30.12.25
30.12.25

